The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial safety assessment of the endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer: NRG-GI007.
 
Geoffrey Yuyat Ku
Consulting or Advisory Role - Apexigen; AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; I-Mab; Jazz Pharmaceuticals; Merck Sharp & Dohme; Pieris Pharmaceuticals
Research Funding - Adaptimmune (Inst); Arog (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CARsgen Therapeutics (Inst); Daiichi Sankyo (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Oncolys BioPharma (Inst); Pieris Pharmaceuticals (Inst); Triumvira Immunologics, Inc (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Aduro Biotech; AstraZeneca/MedImmune; Bristol-Myers Squibb; ImaBiotech; Merck Sharp & Dohme; Pieris Pharmaceuticals
 
Jennifer Moughan
No Relationships to Disclose
 
Terence Marques Williams
Employment - City of Hope
Honoraria - Reflexion Medical
Speakers' Bureau - Accuray; Reflexion Medical
Research Funding - RefleXion Medical (Inst)
Patents, Royalties, Other Intellectual Property - Albumin-bound chemotherapies developed at the Ohio State University (patent pending).
Travel, Accommodations, Expenses - Reflexion Medical
 
Prasad S. Adusumilli
Consulting or Advisory Role - Atara Biotherapeutics; Bayer; Bio4T2; Carisma Therapeutics; ImmPACT-Bio; Imugene; Johnston & Johnston; Orion; Outpace Bio
Research Funding - Atara Biotherapeutics
Patents, Royalties, Other Intellectual Property - Atara Biotherapeutics
 
Makoto Nishimura
Honoraria - Boston Scientific; Lumendi; Olympus
Consulting or Advisory Role - Boston Scientific; Fujifilm; Olympus
Speakers' Bureau - Olympus
Travel, Accommodations, Expenses - Boston Scientific
 
Adam Yock
Patents, Royalties, Other Intellectual Property - Patent issued regarding an adaptive radiotherapy phantom.
 
Rutika Mehta
Honoraria - ASCO; Bristol-Myers Squibb
Consulting or Advisory Role - ASCO; Astellas Pharma; AVEO (I); BostonGene; Bristol-Myers Squibb; Bristol-Myers Squibb (I); EMD Serono (I); Guardant Health; Immunomedics (I); Lilly; Merck; natera; NCCN/Pfizer (I); Novartis; Seagen; Seagen (I)
Speakers' Bureau - Daiichi Sankyo; Gilead Sciences (I); Natera
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Samuel J. Klempner
Stock and Other Ownership Interests - Nuvalent, Inc.; TP Therapeutics
Honoraria - Merck Serono
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Coherus Biosciences; Daiichi Sankyo/UCB Japan; Exact Sciences; Merck; Mersana; Novartis; Sanofi/Aventis; SERVIER
Research Funding - BeiGene (Inst); Leap Therapeutics (Inst); Silverback Therapeutics (Inst)
Other Relationship - Clinical Care Options; NCCN; Research to Practice
 
Eric David Miller
Research Funding - EMD Serono
Other Relationship - NCCN
 
Theodore S. Hong
Stock and Other Ownership Interests - PanTher Therapeutics
Consulting or Advisory Role - Boston Scientific; Merck; NextCure; Novocure; Syndax; Synthetic Biologics
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); IntraOp (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst)